Add Company
Join Now

NBE-Therapeutics AG Revenue and Competitors

License our Company Data API

Basel,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NBE-Therapeutics AG's estimated annual revenue is currently $8.4M per year.(i)
  • NBE-Therapeutics AG's estimated revenue per employee is $155,000

Employee Data

  • NBE-Therapeutics AG has 54 Employees.(i)
  • NBE-Therapeutics AG grew their employee count by 17% last year.

NBE-Therapeutics AG's People

NameTitleEmail/Phone
1
Research AssistantReveal Email/Phone
2
Research Assistant IIReveal Email/Phone
3
Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is NBE-Therapeutics AG?

At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody drug conjugate platform targeting solid tumors. Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has been able to create a pipeline of ADC product candidates in various stages of development to enter clinical phases to create better treatments for cancer patients in need of more selective drugs.

keywords:N/A

N/A

Total Funding

54

Number of Employees

$8.4M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.8M5417%N/A
#2
$13.8M5590%N/A
#3
$8M617%N/A
#4
$9.9M6130%N/A
#5
$8M61N/AN/A